Error message

  • Deprecated function: Creation of dynamic property MergeQuery::$condition is deprecated in MergeQuery->__construct() (line 1357 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).

Aurobindo Pharma Gets USFDA Nod For Ceftriaxone Injection

India’s leading drug maker, Aurobindo Pharma has got sanction from the US Aurobindo Pharma Gets USFDA Nod For Ceftriaxone InjectionFood and Drug Administration (USFDA) for Ceftriaxone injection.

Ceftriaxone is a yellowish-orange crystalline powder belongs to group of antibiotics named cephalosporins, which is used as injection in the treatment of severe infections.

It is available in five strengths i.e. 250 mg, 500 mg, 1g, 2g and 10g.

Shares of the company closed up Rs 7.55, or 2.71%, at Rs 286.4. The total volume of shares traded at the BSE was 39,689.

Error | TopNews

Under Maintenance

The website encountered an unexpected error. Please try again later.